What is the latest UNICHEMLAB stock price?
The latest stored price for UNICHEMLAB is Rs 595.60 as of 2026-07-20.
gimli
UNICHEMLAB stock AI analysis
UNICHEMLAB Stock AI Analysis: Price, PE, 50DMA, Shareholding and Peers
UNICHEM LABORATORIES LTD is a small-cap stock in Healthcare. This Gimli page shows the latest available UNICHEMLAB price, returns, 50DMA/200DMA trend, PE, ROE, ROCE, financials, shareholding pattern, and industry peers for Indian stock screening research.
Price
₹595.60
1W return
-0.23%
1M return
+34.05%
3M return
+72.41%
6M return
+54.94%
1Y return
-5.11%
Market cap
₹4,193.36 cr
PE
16.59
PB
1.54
ROE
+9.78%
ROCE
+10.57%
RSI
66.76
Turnover
₹6.20 cr
Why it can matter in screens
- Momentum: UNICHEMLAB is above 50DMA, above 200DMA; RSI is 66.76.
- Returns: 1D +1.11%, 1W -0.23%, 1M +34.05%, 3M +72.41%, 1Y -5.11%.
- Trend levels: 52W high ₹650.60, 52W low ₹284.05, off high -8.45%.
- Liquidity: latest turnover is ₹6.20 cr; volume vs 20D is +0.12%.
- Valuation/profitability: PE 16.59, PB 1.54, ROE +9.78%, ROCE +10.57%.
- Growth: 3Y sales CAGR +19.12%, 3Y profit CAGR n/a.
Quick Answers
Is UNICHEMLAB above its 50DMA and 200DMA?
UNICHEMLAB is above 50DMA, above 200DMA. The latest 50DMA is 441.53 and the latest 200DMA is 416.71.
What are UNICHEMLAB PE, ROE and ROCE?
UNICHEMLAB has PE 16.59, ROE +9.78%, and ROCE +10.57% in Gimli's latest available snapshot.
How has UNICHEMLAB performed recently?
UNICHEMLAB has returned +34.05% over 1 month, +72.41% over 3 months, and -5.11% over 12 months in the latest stored data.
Is this stock page investment advice?
No. This page is a data snapshot for screening and research. It is not buy, sell, legal, tax, or investment advice.
Financials and Ownership
Quarterly income statement
| Period | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2026-03-31 | 575.12 cr | 58.79 cr | 10.91 cr | 1.55 |
| 2025-12-31 | 521.17 cr | 332.10 cr | 264.29 cr | 37.54 |
| 2025-09-30 | 578.96 cr | 28.89 cr | -11.89 cr | -1.69 |
| 2025-06-30 | 526.60 cr | 29.31 cr | -10.47 cr | -1.49 |
| 2025-03-31 | 587.18 cr | 92.95 cr | 52.97 cr | 7.52 |
| 2024-12-31 | 533.09 cr | 99.14 cr | 57.85 cr | 8.22 |
| 2024-09-30 | 462.16 cr | 66.32 cr | n/a | 3.50 |
| 2024-06-30 | 483.34 cr | 43.91 cr | 2.07 cr | 0.29 |
Annual income statement
| Year | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2026-03-31 | 2,201.85 cr | 449.09 cr | 252.84 cr | 35.91 |
| 2025-03-31 | 2,110.97 cr | 300.18 cr | 137.52 cr | 19.53 |
| 2024-03-31 | 1,737.63 cr | 60.35 cr | -93.76 cr | -13.32 |
| 2023-03-31 | 1,302.42 cr | -46.67 cr | -202.23 cr | -28.72 |
| 2022-03-31 | 984.99 cr | 118.22 cr | -55.43 cr | -7.87 |
Balance sheet
| Period | Assets | Cash | Debt | Equity |
|---|---|---|---|---|
| 2026-03-31 | 3,737.44 cr | 289.48 cr | 500.15 cr | 2,717.44 cr |
| 2025-03-31 | 3,569.40 cr | 89.58 cr | 459.77 cr | 2,450.59 cr |
| 2024-03-31 | 3,274.95 cr | 154.75 cr | 247.52 cr | 2,438.30 cr |
| 2023-03-31 | 3,193.05 cr | 183.75 cr | 314.05 cr | 2,435.30 cr |
| 2022-03-31 | 3,318.77 cr | 109.20 cr | 349.15 cr | 2,618.41 cr |
Cash flow
| Period | OCF | FCF | Cash change |
|---|---|---|---|
| 2026-03-31 | 3.64 cr | -119.40 cr | n/a |
| 2025-03-31 | -7.02 cr | -144.38 cr | n/a |
| 2024-03-31 | 14.00 cr | -8.55 cr | n/a |
| 2023-03-31 | -85.09 cr | -129.41 cr | n/a |
| 2022-03-31 | -259.61 cr | -386.61 cr | n/a |
Shareholding Trend
| Period | Promoter | FII/FPI | DII | MF | Retail | Pledge |
|---|---|---|---|---|---|---|
| 2026-06-30 | +70.22% | +0.90% | +10.46% | +9.32% | +18.42% | +0.00% |
| 2026-03-31 | +70.22% | +1.00% | +10.63% | +9.07% | +18.15% | +0.00% |
| 2025-12-31 | +70.22% | +0.99% | +10.74% | +9.17% | +18.05% | +0.00% |
| 2025-09-30 | +70.22% | +1.00% | +10.75% | +9.17% | +18.03% | +0.00% |
| 2025-06-30 | +70.22% | +0.98% | +10.92% | +9.39% | +17.88% | +0.00% |
| 2025-03-31 | +70.22% | +0.98% | +11.32% | +9.89% | +17.48% | +0.00% |
| 2024-12-31 | +70.22% | +1.06% | +11.63% | +10.20% | +17.09% | +0.00% |
| 2024-09-30 | +70.22% | +0.94% | +11.67% | +10.22% | +17.18% | +0.00% |
| 2024-06-30 | +70.22% | +0.89% | +11.58% | +10.14% | +17.30% | +0.00% |
| 2024-03-31 | +70.22% | +0.90% | +11.27% | +9.77% | +17.61% | +0.00% |
| 2023-12-31 | +70.22% | +0.84% | +10.75% | +9.03% | +18.18% | n/a |
| 2023-09-30 | +70.21% | +0.83% | +10.32% | +8.56% | +18.64% | +0.00% |
| 2023-06-30 | +50.93% | +1.62% | +9.73% | +6.11% | +37.72% | +0.00% |
| 2023-03-31 | +50.93% | +1.70% | +8.16% | +6.69% | +39.21% | +0.00% |
| 2022-12-31 | +50.93% | +1.56% | +8.20% | +6.78% | +39.30% | +0.00% |
| 2022-09-30 | +50.93% | +1.71% | +8.70% | +7.29% | +38.66% | +0.00% |
| 2022-06-30 | +50.93% | +0.00% | +11.03% | n/a | n/a | +0.00% |
| 2022-03-31 | +50.93% | +0.00% | +11.06% | n/a | n/a | +0.00% |
| 2021-12-31 | +50.93% | +0.00% | +10.75% | n/a | n/a | +0.00% |
| 2021-09-30 | +50.93% | +0.00% | +10.62% | n/a | n/a | +0.00% |
Industry Peers
| Symbol | Name | Mcap | PE | ROE | 1Y |
|---|---|---|---|---|---|
| SUNPHARMA | SUN PHARMACEUTICAL IND L | 469,405.90 cr | 40.823336 | +14.71% | +15.52% |
| DIVISLAB | DIVI S LABORATORIES LTD | 194,269.92 cr | 75.650281 | +16.19% | +8.71% |
| TORNTPHARM | TORRENT PHARMACEUTICALS L | 169,405.46 cr | 78.319677 | +17.18% | +42.14% |
| APOLLOHOSP | APOLLO HOSPITALS ENTER. L | 128,040.28 cr | 65.380043 | +21.03% | +21.93% |
| CIPLA | CIPLA LTD | 116,452.52 cr | 30.005339 | +11.79% | -2.75% |
| ZYDUSLIFE | ZYDUS LIFESCIENCES LTD | 115,616.29 cr | 23.056854 | +17.93% | +17.85% |
| LUPIN | LUPIN LIMITED | 113,320.96 cr | 21.221472 | +26.83% | +28.27% |
| MAXHEALTH | MAX HEALTHCARE INS LTD | 107,290.40 cr | 74.382732 | +14.33% | -9.32% |
Try these prompts
- Analyze UNICHEM LABORATORIES with valuation, momentum and industry peers
- Compare UNICHEMLAB with other Healthcare stocks
- Show small-cap stocks in Healthcare above 50DMA with positive 1M return
- Find Healthcare stocks with improving momentum and reasonable valuation
Related screen ideas
- View Healthcare stocks
- View small-cap stocks
- Find stocks above 50DMA
- Compare UNICHEMLAB with other Healthcare stocks
Data snapshot: 2026-07-20. Not investment advice.